Richard Hopkins
Follow
Get notifications in MyBN when activity occurs.
Richard Hopkins
Non-Executive Director / BlinkLab
Richard Hopkins is a founder of Phylogica and had been the chief executive since July 2013; he announced his resignation in July 2016. He then became chief executive of PharmAust Pharmaceutical for a year before becoming chief executive and managing director of Zelira Therapeutics in July 2018. He left Zelira in May 2021 following a strategic consolidation by the company to have its leadership team based in the US.
His most recent research was focused on engineering peptide leads for drug development. Dr Hopkins has published over 20 peer reviewed papers and is a co-inventor on over 10 patent applications.
His most recent research was focused on engineering peptide leads for drug development. Dr Hopkins has published over 20 peer reviewed papers and is a co-inventor on over 10 patent applications.
Lists and Charts
Total Shareholder Return as at 31/10/24
| Rank | Company | 1 yr | 5 yr |
|---|---|---|---|
| th | BlinkLab |
1740 WA (and selected non WA) listed companies ranked by
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
1 year TSR relative to other companies with similar revenue
Powered by Morningstar ®
Roles
Year started and most recent title
Share Transactions
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| th |  | BlinkLab | $37k |
200 listed industrial wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
| NEW ROLE: Non-Executive Director, BlinkLab | 13 May 2024 |
| NEWS: Tagged in BlinkLab shares soar on ASX debut | 04 Apr 2024 |
| REMUNERATION UPDATE: Managing Director, Zelira Therapeutics | 02 Nov 2020 |
